Penumbra Stock Performance
| PEN Stock | USD 288.47 8.68 3.10% |
Penumbra has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.0059, which implies not very significant fluctuations relative to the market. As returns on the market increase, Penumbra's returns are expected to increase less than the market. However, during the bear market, the loss of holding Penumbra is expected to be smaller as well. Penumbra right now holds a risk of 2.87%. Please check Penumbra maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to decide if Penumbra will be following its historical price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Penumbra are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Penumbra may actually be approaching a critical reversion point that can send shares even higher in December 2025. ...more
| Begin Period Cash Flow | 167.5 M | |
| Total Cashflows From Investing Activities | 77.6 M |
Penumbra Relative Risk vs. Return Landscape
If you would invest 26,417 in Penumbra on August 23, 2025 and sell it today you would earn a total of 2,430 from holding Penumbra or generate 9.2% return on investment over 90 days. Penumbra is generating 0.176% of daily returns assuming volatility of 2.8722% on return distribution over 90 days investment horizon. In other words, 25% of stocks are less volatile than Penumbra, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Penumbra Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Penumbra's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Penumbra, and traders can use it to determine the average amount a Penumbra's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0613
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PEN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.87 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Penumbra is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Penumbra by adding it to a well-diversified portfolio.
Penumbra Fundamentals Growth
Penumbra Stock prices reflect investors' perceptions of the future prospects and financial health of Penumbra, and Penumbra fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Penumbra Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.067 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 10.84 B | ||||
| Shares Outstanding | 39.16 M | ||||
| Price To Earning | 191.13 X | ||||
| Price To Book | 8.16 X | ||||
| Price To Sales | 8.21 X | ||||
| Revenue | 1.19 B | ||||
| EBITDA | 45.99 M | ||||
| Cash And Equivalents | 324.4 M | ||||
| Cash Per Share | 5.39 X | ||||
| Total Debt | 223.39 M | ||||
| Debt To Equity | 0.23 % | ||||
| Book Value Per Share | 34.70 X | ||||
| Cash Flow From Operations | 168.48 M | ||||
| Earnings Per Share | 4.19 X | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 60 M | ||||
| Current Asset | 244.36 M | ||||
| Current Liabilities | 28.15 M | ||||
About Penumbra Performance
By examining Penumbra's fundamental ratios, stakeholders can obtain critical insights into Penumbra's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Penumbra is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people.Things to note about Penumbra performance evaluation
Checking the ongoing alerts about Penumbra for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Penumbra help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Penumbra has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors |
- Analyzing Penumbra's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Penumbra's stock is overvalued or undervalued compared to its peers.
- Examining Penumbra's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Penumbra's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Penumbra's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Penumbra's stock. These opinions can provide insight into Penumbra's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.